ESOMEPRAZOLE SODIUM

ESOMEPRAZOLE SODIUM was reported 2436 times

ESOMEPRAZOLE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEGENERATIVE MITRAL VALVE DISEASE 4 0.0889
1 PULMONARY VALVE DISEASE 11 0.0846
2 ANGINA BULLOSA HAEMORRHAGICA 18 0.0776
3 NONALCOHOLIC FATTY LIVER DISEASE 15 0.0765
4 HEPATOJUGULAR REFLUX 12 0.0723
5 SYNOVIAL FLUID ANALYSIS 5 0.0575
6 ELECTROCARDIOGRAM Q WAVE ABNORMAL 12 0.0513
7 NEUROLOGIC NEGLECT SYNDROME 28 0.0504
8 CAROTID ARTERY THROMBOSIS 30 0.0353
9 AMAUROSIS FUGAX 37 0.0344
10 MULTI-ORGAN DISORDER 57 0.0289
11 VULVAL DISORDER 19 0.0287
12 PHYSICAL EXAMINATION ABNORMAL 11 0.0287
13 VAGUS NERVE DISORDER 7 0.0280
14 ADJUSTMENT DISORDER 35 0.0269
15 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 2 0.0253
16 OCCULT BLOOD 13 0.0248
17 EAR, NOSE AND THROAT INFECTION 2 0.0244
18 VENTRICULAR ENLARGEMENT 4 0.0227
19 IMMUNISATION 9 0.0207
20 MUSCLE SWELLING 19 0.0207
21 FACIAL ASYMMETRY 19 0.0199
22 WITHDRAWAL HYPERTENSION 4 0.0198
23 CARDIOSPASM 11 0.0197
24 INFERIOR VENA CAVA DILATATION 4 0.0190
25 FEMALE REPRODUCTIVE TRACT DISORDER 4 0.0183
26 NON-ALCOHOLIC FATTY LIVER 6 0.0178
27 BILE ACIDS INCREASED 3 0.0169
28 MONOCLONAL GAMMOPATHY 10 0.0159
29 POVERTY OF SPEECH 6 0.0153
30 SYSTOLIC DYSFUNCTION 16 0.0152
31 HEART FAILURE WITH REDUCED EJECTION FRACTION 8 0.0150
32 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 4 0.0147
33 PALMOPLANTAR KERATODERMA 10 0.0138
34 CEREBRAL ARTERY THROMBOSIS 7 0.0136
35 VASCULAR GRAFT OCCLUSION 5 0.0130
36 HAEMORRHAGIC CYST 5 0.0129
37 BRAIN SCAN ABNORMAL 7 0.0125
38 PALMAR ERYTHEMA 14 0.0121
39 CAROTID ARTERIOSCLEROSIS 12 0.0116
40 TENOSYNOVITIS STENOSANS 6 0.0108
41 PERSONALITY DISORDER 28 0.0107
42 EARLY SATIETY 19 0.0098
43 HELICOBACTER GASTRITIS 12 0.0097
44 SUPERFICIAL VEIN THROMBOSIS 8 0.0095
45 MITE ALLERGY 6 0.0092
46 POST PROCEDURAL DISCHARGE 6 0.0089
47 SEPTIC ARTHRITIS STAPHYLOCOCCAL 3 0.0086
48 PULMONARY VASCULAR DISORDER 4 0.0085
49 CREPITATIONS 24 0.0081
50 POSTURING 4 0.0077
51 METASTASES TO THE MEDIASTINUM 3 0.0073
52 GRAVITATIONAL OEDEMA 5 0.0072
53 HELICOBACTER TEST POSITIVE 4 0.0071
54 TONGUE PRURITUS 6 0.0070
55 AUTONOMIC NEUROPATHY 7 0.0069
56 DYSPNOEA AT REST 20 0.0069
57 GINGIVAL ABSCESS 5 0.0066
58 GANGRENE 40 0.0066
59 ATYPICAL FRACTURE 4 0.0065
60 ECHOCARDIOGRAM ABNORMAL 9 0.0064
61 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 4 0.0062
62 MITRAL VALVE DISEASE 11 0.0062
63 LIVER ABSCESS 20 0.0062
64 GRANULOMA SKIN 5 0.0061
65 MALNUTRITION 68 0.0061
66 HYPERCREATININAEMIA 3 0.0060
67 THROMBOPHLEBITIS SUPERFICIAL 18 0.0059
68 RALES 34 0.0058
69 BLOOD PRESSURE DIASTOLIC INCREASED 27 0.0058
70 SACROILIITIS 11 0.0058
71 ALLERGY TO ANIMAL 6 0.0056
72 DELAYED GRAFT FUNCTION 4 0.0056
73 ANAEMIA MACROCYTIC 12 0.0056
74 CARDIAC DISCOMFORT 11 0.0055
75 VENTRICULAR HYPOKINESIA 17 0.0053
76 HEAT STROKE 8 0.0053
77 VENTRICULAR ARRHYTHMIA 19 0.0052
78 BUNDLE BRANCH BLOCK LEFT 22 0.0052
79 PRURITUS ALLERGIC 6 0.0051
80 ATROPHY 10 0.0051
81 HYPOCHLORAEMIA 6 0.0051
82 ARTERIAL OCCLUSIVE DISEASE 40 0.0051
83 GOUTY ARTHRITIS 4 0.0050
84 BASAL GANGLIA HAEMORRHAGE 4 0.0049
85 NAIL INFECTION 7 0.0049
86 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
87 DERMATOSIS 3 0.0048
88 TEETH BRITTLE 5 0.0048
89 PRODUCT USED FOR UNKNOWN INDICATION 6 0.0048
90 ATRIAL TACHYCARDIA 10 0.0048
91 HYPOPROTEINAEMIA 9 0.0047
92 PRURITUS GENITAL 11 0.0047
93 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 11 0.0046
94 NASAL CRUSTING 3 0.0046
95 HAEMORRHAGIC STROKE 36 0.0046
96 SCLERITIS 7 0.0044
97 HEMIPLEGIA 36 0.0043
98 EYE HAEMORRHAGE 57 0.0043
99 PROCALCITONIN INCREASED 5 0.0043
100 STENOSIS 8 0.0043
101 BLOOD ALKALINE PHOSPHATASE DECREASED 4 0.0042
102 DIASTOLIC DYSFUNCTION 13 0.0042
103 THYROID DISORDER 64 0.0041
104 CARDIAC ANEURYSM 4 0.0040
105 GASTRITIS HAEMORRHAGIC 6 0.0040
106 ACTINIC KERATOSIS 10 0.0038
107 LEFT VENTRICULAR HYPERTROPHY 16 0.0037
108 SENSORY LOSS 30 0.0037
109 RHEUMATOID NODULE 10 0.0036
110 MYELITIS TRANSVERSE 5 0.0035
111 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
112 BLADDER TRANSITIONAL CELL CARCINOMA 5 0.0035
113 COLON INJURY 2 0.0035
114 EPIDIDYMITIS 4 0.0034
115 BLOOD PARATHYROID HORMONE DECREASED 5 0.0034
116 ENTEROCOLITIS INFECTIOUS 3 0.0033
117 OCULAR DISCOMFORT 36 0.0032
118 INTRADUCTAL PROLIFERATIVE BREAST LESION 4 0.0032
119 CAROTID ARTERY STENOSIS 11 0.0031
120 BODY TEMPERATURE DECREASED 31 0.0031
121 ANAL INFLAMMATION 2 0.0031
122 TOTAL LUNG CAPACITY DECREASED 5 0.0031
123 AFFECT LABILITY 30 0.0031
124 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
125 SOPOR 41 0.0031
126 PERICARDIAL EFFUSION 71 0.0031
127 OBLITERATIVE BRONCHIOLITIS 4 0.0030
128 ANISOCYTOSIS 2 0.0030
129 MOTOR DYSFUNCTION 31 0.0030
130 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
131 ANGULAR CHEILITIS 2 0.0029
132 SLOW SPEECH 7 0.0029
133 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
134 AORTIC VALVE INCOMPETENCE 12 0.0028
135 SMALL INTESTINAL STENOSIS 3 0.0028
136 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
137 BLOOD FOLATE DECREASED 2 0.0028
138 ARRHYTHMIA SUPRAVENTRICULAR 3 0.0027
139 CAROTID ARTERY OCCLUSION 10 0.0027
140 NORMOCYTIC ANAEMIA 4 0.0027
141 ESSENTIAL TREMOR 3 0.0027
142 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
143 URINARY TRACT DISORDER 12 0.0027
144 HAEMORRHAGIC TRANSFORMATION STROKE 4 0.0027
145 ORAL MUCOSAL EXFOLIATION 4 0.0026
146 BRONCHITIS BACTERIAL 2 0.0026
147 BASOPHIL COUNT INCREASED 2 0.0026
148 AREFLEXIA 7 0.0026
149 TONGUE OEDEMA 10 0.0026
150 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
151 OCCULT BLOOD POSITIVE 5 0.0025
152 RECTAL PROLAPSE 3 0.0025
153 MONOCYTE COUNT DECREASED 3 0.0025
154 BRADYPHRENIA 16 0.0024
155 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
156 BLOOD MAGNESIUM DECREASED 21 0.0024
157 MUCOUS STOOLS 12 0.0024
158 CORONARY ARTERY STENOSIS 12 0.0024
159 SLEEP TERROR 10 0.0024
160 HEAD DISCOMFORT 42 0.0024
161 TENSION HEADACHE 10 0.0023
162 SINUS CONGESTION 31 0.0023
163 MUSCLE SPASTICITY 28 0.0023
164 ABDOMINAL SEPSIS 2 0.0023
165 IMMUNOGLOBULINS DECREASED 3 0.0022
166 BONE CONTUSION 2 0.0022
167 COORDINATION ABNORMAL 30 0.0021
168 ANGIOPATHY 12 0.0021
169 BRONCHIAL OBSTRUCTION 3 0.0021
170 INGROWING NAIL 5 0.0021
171 SMEAR CERVIX ABNORMAL 3 0.0021
172 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
173 PANNICULITIS 5 0.0021
174 ABDOMINAL WALL HAEMATOMA 4 0.0020
175 ULCER 32 0.0020
176 BLOOD CALCIUM DECREASED 22 0.0020
177 ANGINA PECTORIS 56 0.0020
178 HYPERURICAEMIA 8 0.0019
179 HYPOALBUMINAEMIA 15 0.0019
180 URINE KETONE BODY PRESENT 3 0.0019
181 SKIN HAEMORRHAGE 28 0.0019
182 HEMIPARESIS 32 0.0019
183 RESPIRATORY TRACT CONGESTION 30 0.0019
184 BREAST PAIN 20 0.0019
185 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
186 HAEMATEMESIS 46 0.0018
187 MEAN CELL HAEMOGLOBIN INCREASED 3 0.0018
188 PLEURITIC PAIN 5 0.0018
189 LYMPHOCYTE COUNT DECREASED 32 0.0018
190 HEART RATE ABNORMAL 10 0.0018
191 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
192 DRUG TOLERANCE DECREASED 5 0.0018
193 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
194 TRICUSPID VALVE INCOMPETENCE 14 0.0018
195 VENTRICULAR TACHYCARDIA 29 0.0018
196 VITAMIN B12 DEFICIENCY 7 0.0017
197 NEUROLOGICAL DECOMPENSATION 4 0.0017
198 MASS 24 0.0017
199 SINUS DISORDER 34 0.0017
200 DILATATION ATRIAL 2 0.0017
201 VERTIGO POSITIONAL 3 0.0017
202 BILIRUBIN CONJUGATED INCREASED 4 0.0017
203 FEBRILE INFECTION 2 0.0017
204 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
205 ONYCHOMADESIS 7 0.0017
206 DUODENITIS 5 0.0016
207 ASCITES 47 0.0016
208 BLOOD BICARBONATE DECREASED 3 0.0016
209 RHINITIS ALLERGIC 7 0.0016
210 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
211 ADENOCARCINOMA PANCREAS 2 0.0016
212 CUSHINGOID 5 0.0016
213 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
214 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
215 IMMUNE-MEDIATED HEPATIC DISORDER 3 0.0015
216 ENCEPHALITIS AUTOIMMUNE 2 0.0015
217 SYNOVIAL CYST 7 0.0015
218 CELL DEATH 3 0.0015
219 ARTHRITIS 118 0.0015
220 EFFUSION 2 0.0015
221 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
222 KIDNEY TRANSPLANT REJECTION 7 0.0015
223 QUADRIPLEGIA 3 0.0015
224 IMMUNE-MEDIATED MYOSITIS 4 0.0014
225 JOINT EFFUSION 10 0.0014
226 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
227 CULTURE URINE POSITIVE 2 0.0014
228 HYPERPYREXIA 6 0.0014
229 MITRAL VALVE INCOMPETENCE 16 0.0014
230 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
231 FIBRIN D DIMER INCREASED 5 0.0014
232 HYPERAMMONAEMIA 7 0.0014
233 HEART VALVE INCOMPETENCE 4 0.0014
234 HYPERCALCAEMIA 17 0.0014
235 SEDATION 36 0.0014
236 VASCULITIS 16 0.0014
237 CEREBELLAR SYNDROME 3 0.0014
238 NEUTROPHIL COUNT INCREASED 14 0.0014
239 EATING DISORDER 29 0.0014
240 MALABSORPTION 7 0.0013
241 PULMONARY OEDEMA 60 0.0013
242 BLOOD PRESSURE FLUCTUATION 32 0.0013
243 CATATONIA 7 0.0013
244 HAEMORRHOIDS 26 0.0013
245 GASTRIC POLYPS 3 0.0013
246 EYE INJURY 4 0.0013
247 BLOOD PRESSURE IMMEASURABLE 2 0.0013
248 GINGIVAL DISORDER 5 0.0013
249 SNEEZING 29 0.0013
250 HYDROCEPHALUS 7 0.0013
251 HYPOKALAEMIA 59 0.0013
252 HYPERLIPIDAEMIA 15 0.0013
253 PNEUMONIA VIRAL 4 0.0013
254 LACUNAR INFARCTION 3 0.0013
255 INTENTIONAL SELF-INJURY 25 0.0012
256 APHASIA 37 0.0012
257 PERIPHERAL VENOUS DISEASE 5 0.0012
258 HYPOMAGNESAEMIA 17 0.0012
259 HAND DEFORMITY 16 0.0012
260 BREATH SOUNDS ABNORMAL 6 0.0012
261 HYPOCALCAEMIA 23 0.0012
262 RHEUMATOID FACTOR POSITIVE 7 0.0012
263 SPINAL STENOSIS 5 0.0012
264 BLINDNESS 49 0.0012
265 NEUTROPHIL COUNT DECREASED 49 0.0012
266 BIPOLAR DISORDER 13 0.0012
267 TACHYCARDIA 106 0.0012
268 BRADYKINESIA 7 0.0012
269 DYSPHORIA 6 0.0012
270 SKIN PLAQUE 10 0.0012
271 DRUG ERUPTION 21 0.0012
272 HEPATIC CIRRHOSIS 22 0.0012
273 MENOPAUSE 3 0.0012
274 REGURGITATION 4 0.0012
275 HIATUS HERNIA 15 0.0012
276 NIGHTMARE 40 0.0012
277 FAECES DISCOLOURED 25 0.0012
278 CARDIOMEGALY 14 0.0011
279 SERUM FERRITIN INCREASED 6 0.0011
280 GENERALISED OEDEMA 14 0.0011
281 FACIAL PAIN 10 0.0011
282 TOOTH FRACTURE 12 0.0011
283 IMMUNE-MEDIATED ENTEROCOLITIS 4 0.0011
284 METASTASES TO LIVER 19 0.0011
285 SUBARACHNOID HAEMORRHAGE 11 0.0011
286 CARDIO-RESPIRATORY ARREST 45 0.0011
287 GASTRITIS EROSIVE 5 0.0011
288 POOR VENOUS ACCESS 11 0.0011
289 CHOLECYSTITIS ACUTE 6 0.0011
290 SPINAL DISORDER 10 0.0011
291 FACIAL PARALYSIS 9 0.0011
292 TUMOUR HAEMORRHAGE 3 0.0011
293 COMA 50 0.0010
294 COMMUNICATION DISORDER 4 0.0010
295 HYPOVOLAEMIC SHOCK 5 0.0010
296 EXERCISE TOLERANCE DECREASED 6 0.0010
297 GASTROINTESTINAL INFLAMMATION 8 0.0010
298 ONYCHOCLASIS 7 0.0010
299 PHOTOPHOBIA 19 0.0010
300 CYSTITIS 32 0.0010
301 ANORECTAL DISORDER 2 0.0010
302 DIPLOPIA 26 0.0010
303 DERMATITIS EXFOLIATIVE 5 0.0010
304 LUNG ADENOCARCINOMA 3 0.0010
305 HYPERTENSIVE CRISIS 11 0.0010
306 DYSARTHRIA 37 0.0010
307 PHLEBITIS 5 0.0010
308 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
309 CHILLS 114 0.0010
310 NEUROPATHY PERIPHERAL 92 0.0010
311 EJECTION FRACTION DECREASED 15 0.0010
312 SKIN NECROSIS 5 0.0010
313 FREQUENT BOWEL MOVEMENTS 26 0.0010
314 SUICIDAL BEHAVIOUR 4 0.0010
315 BODY TEMPERATURE FLUCTUATION 2 0.0010
316 BLOOD CREATININE DECREASED 3 0.0010
317 CHEST DISCOMFORT 98 0.0010
318 PRODUCTIVE COUGH 45 0.0009
319 LIVER INJURY 23 0.0009
320 PALLOR 25 0.0009
321 LIGAMENT RUPTURE 4 0.0009
322 PEPTIC ULCER 3 0.0009
323 CONCUSSION 7 0.0009
324 BLOOD CREATINE INCREASED 4 0.0009
325 MOVEMENT DISORDER 29 0.0009
326 CHOLESTATIC LIVER INJURY 2 0.0009
327 BACTERIAL TEST POSITIVE 2 0.0009
328 GOUT 16 0.0009
329 SUSPECTED OFF LABEL USE 4 0.0009
330 CHOLELITHIASIS 29 0.0009
331 ABNORMAL LOSS OF WEIGHT 6 0.0009
332 GRANULOCYTOPENIA 5 0.0009
333 IMMUNE THROMBOCYTOPENIA 4 0.0009
334 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
335 LEFT VENTRICULAR FAILURE 3 0.0009
336 DEPRESSION SUICIDAL 3 0.0009
337 DIVERTICULITIS 24 0.0009
338 TENDERNESS 9 0.0009
339 FLANK PAIN 8 0.0009
340 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
341 DEPRESSIVE SYMPTOM 3 0.0009
342 EYE PAIN 48 0.0008
343 JAUNDICE CHOLESTATIC 3 0.0008
344 COVID-19 PNEUMONIA 10 0.0008
345 HYPOGLYCAEMIA 41 0.0008
346 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
347 BODY HEIGHT DECREASED 9 0.0008
348 GASTROINTESTINAL TOXICITY 4 0.0008
349 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
350 MONOCYTE COUNT INCREASED 3 0.0008
351 CATARACT 49 0.0008
352 FIBROMYALGIA 20 0.0008
353 HAEMATURIA 28 0.0008
354 HEART RATE INCREASED 81 0.0008
355 ANURIA 7 0.0008
356 HYPOPHOSPHATAEMIA 6 0.0008
357 PIGMENTATION DISORDER 5 0.0008
358 DRUG INTOLERANCE 78 0.0008
359 NIGHT SWEATS 26 0.0008
360 IMPAIRED GASTRIC EMPTYING 11 0.0008
361 HEPATIC STEATOSIS 15 0.0008
362 SKIN LESION 22 0.0008
363 OVARIAN CYST 8 0.0008
364 PROTEIN TOTAL DECREASED 3 0.0008
365 NEEDLE ISSUE 23 0.0008
366 TINNITUS 36 0.0008
367 FEAR 21 0.0008
368 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
369 BLOOD CHLORIDE DECREASED 2 0.0008
370 PERICARDITIS 13 0.0008
371 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
372 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
373 VENOUS THROMBOSIS 3 0.0008
374 HEPATOTOXICITY 17 0.0008
375 HYPONATRAEMIA 43 0.0008
376 ANOSMIA 11 0.0008
377 CARDIAC FAILURE CONGESTIVE 61 0.0008
378 RHEUMATOID ARTHRITIS 86 0.0008
379 PALPITATIONS 88 0.0008
380 ANIMAL BITE 2 0.0007
381 PLATELET COUNT DECREASED 80 0.0007
382 ANAL FISTULA 4 0.0007
383 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
384 ABDOMINAL PAIN UPPER 154 0.0007
385 MUSCLE HAEMORRHAGE 3 0.0007
386 ORTHOSTATIC HYPOTENSION 13 0.0007
387 FUNGAL SKIN INFECTION 3 0.0007
388 PERIPHERAL ISCHAEMIA 3 0.0007
389 CLUMSINESS 2 0.0007
390 BLOOD PHOSPHORUS INCREASED 2 0.0007
391 FAECALOMA 4 0.0007
392 ECCHYMOSIS 5 0.0007
393 BLOOD PRESSURE DECREASED 48 0.0007
394 GASTRITIS 19 0.0007
395 CHOLECYSTITIS INFECTIVE 2 0.0007
396 HYPERTRANSAMINASAEMIA 5 0.0007
397 INTRACRANIAL PRESSURE INCREASED 4 0.0007
398 GASTROINTESTINAL DISORDER 64 0.0007
399 RASH PAPULAR 16 0.0007
400 BLOOD PRESSURE INCREASED 108 0.0007
401 UPPER LIMB FRACTURE 14 0.0007
402 DRUG-INDUCED LIVER INJURY 22 0.0007
403 ARRHYTHMIA 33 0.0007
404 UPPER RESPIRATORY TRACT INFECTION 32 0.0007
405 TOOTH ABSCESS 7 0.0007
406 PULMONARY FUNCTION TEST DECREASED 3 0.0007
407 TYPE 2 DIABETES MELLITUS 23 0.0007
408 ORAL DISORDER 5 0.0007
409 COLD SWEAT 12 0.0007
410 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
411 RESPIRATORY RATE INCREASED 6 0.0007
412 SEPSIS 75 0.0007
413 HEPATIC FUNCTION ABNORMAL 25 0.0007
414 INTESTINAL OBSTRUCTION 25 0.0007
415 TACHYPNOEA 9 0.0007
416 URINE ABNORMALITY 3 0.0007
417 EMBOLISM VENOUS 2 0.0007
418 BURSITIS 8 0.0007
419 PRESYNCOPE 16 0.0007
420 HAEMOGLOBIN INCREASED 3 0.0007
421 HEART RATE DECREASED 23 0.0007
422 LIPASE INCREASED 5 0.0007
423 MUSCLE TWITCHING 15 0.0007
424 DRUG ABUSE 54 0.0006
425 INTERCEPTED MEDICATION ERROR 3 0.0006
426 CONJUNCTIVITIS 12 0.0006
427 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
428 MYELOSUPPRESSION 23 0.0006
429 RHINORRHOEA 41 0.0006
430 NEPHROLITHIASIS 29 0.0006
431 NERVE INJURY 7 0.0006
432 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
433 ATELECTASIS 6 0.0006
434 FRUSTRATION TOLERANCE DECREASED 5 0.0006
435 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
436 HEPATITIS ACUTE 4 0.0006
437 MUSCULOSKELETAL PAIN 32 0.0006
438 NASAL POLYPS 3 0.0006
439 ELECTROLYTE IMBALANCE 7 0.0006
440 CYTOLYTIC HEPATITIS 2 0.0006
441 EYELID OEDEMA 7 0.0006
442 HYPERNATRAEMIA 3 0.0006
443 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
444 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
445 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
446 CORONARY ARTERY DISEASE 18 0.0006
447 HYPOTHERMIA 6 0.0006
448 FEEDING DISORDER 12 0.0006
449 MELAENA 13 0.0006
450 PERIPHERAL COLDNESS 8 0.0006
451 MUSCULOSKELETAL CHEST PAIN 9 0.0006
452 TEMPERATURE INTOLERANCE 6 0.0006
453 RESPIRATION ABNORMAL 4 0.0006
454 ABDOMINAL PAIN 135 0.0006
455 TREATMENT FAILURE 48 0.0006
456 PERIORBITAL OEDEMA 3 0.0006
457 C-REACTIVE PROTEIN INCREASED 21 0.0006
458 ACUTE MYOCARDIAL INFARCTION 17 0.0006
459 LARGE INTESTINE PERFORATION 4 0.0006
460 HEART RATE IRREGULAR 13 0.0006
461 HYPERHIDROSIS 74 0.0006
462 PULMONARY FIBROSIS 11 0.0006
463 INFUSION RELATED REACTION 38 0.0006
464 DEFAECATION URGENCY 4 0.0006
465 ERYTHEMA NODOSUM 2 0.0006
466 SPINAL OSTEOARTHRITIS 5 0.0006
467 BLOOD CREATININE INCREASED 37 0.0006
468 ANGIOEDEMA 25 0.0006
469 DIVERTICULUM 4 0.0006
470 ISCHAEMIC STROKE 10 0.0006
471 IRRITABLE BOWEL SYNDROME 12 0.0006
472 BLOOD CHOLESTEROL INCREASED 26 0.0006
473 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
474 ANAEMIA 106 0.0006
475 HIP SURGERY 3 0.0006
476 BRAIN OEDEMA 7 0.0006
477 RASH PUSTULAR 4 0.0005
478 DYSSTASIA 16 0.0005
479 SINUSITIS 56 0.0005
480 INFLAMMATION 28 0.0005
481 SKIN ULCER 14 0.0005
482 CHEST PAIN 100 0.0005
483 BLOOD UREA INCREASED 9 0.0005
484 NODULE 7 0.0005
485 MYALGIA 91 0.0005
486 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
487 NASOPHARYNGITIS 98 0.0005
488 CATHETER SITE INFECTION 2 0.0005
489 GASTRIC ULCER 10 0.0005
490 AORTIC ANEURYSM 4 0.0005
491 GASTRIC DISORDER 18 0.0005
492 HYPERCHOLESTEROLAEMIA 5 0.0005
493 RASH PRURITIC 28 0.0005
494 NICOTINE DEPENDENCE 4 0.0005
495 HYPERTRIGLYCERIDAEMIA 3 0.0005
496 HYPERTENSION 108 0.0005
497 RENAL TUBULAR NECROSIS 5 0.0005
498 HEPATOMEGALY 5 0.0005
499 HAEMOGLOBIN DECREASED 52 0.0005
500 ASTHENIA 190 0.0005
501 PLEURISY 3 0.0005
502 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
503 BLOOD ALBUMIN DECREASED 4 0.0005
504 LETHARGY 29 0.0005
505 AZOTAEMIA 2 0.0005
506 SYNCOPE 50 0.0005
507 CYTOKINE RELEASE SYNDROME 10 0.0005
508 HEPATITIS CHOLESTATIC 3 0.0005
509 INTERSTITIAL LUNG DISEASE 24 0.0005
510 INJECTION SITE REACTION 34 0.0005
511 HEPATOCELLULAR INJURY 7 0.0005
512 MUSCULAR WEAKNESS 56 0.0005
513 COGNITIVE DISORDER 23 0.0005
514 PYREXIA 170 0.0005
515 PARALYSIS 7 0.0005
516 LARYNGEAL OEDEMA 3 0.0005
517 CHOLANGITIS 3 0.0005
518 OLIGURIA 3 0.0005
519 PRE-EXISTING CONDITION IMPROVED 3 0.0005
520 LEUKOPENIA 24 0.0005
521 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
522 PETECHIAE 5 0.0005
523 AGITATION 35 0.0005
524 CEREBRAL HAEMORRHAGE 17 0.0005
525 COUGH 133 0.0005
526 BRADYCARDIA 25 0.0005
527 HEPATIC CYTOLYSIS 6 0.0005
528 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
529 CARDIAC FAILURE CHRONIC 2 0.0005
530 WEIGHT DECREASED 131 0.0005
531 METABOLIC ACIDOSIS 15 0.0005
532 ALCOHOLISM 2 0.0005
533 PRURITUS 179 0.0005
534 JOINT SWELLING 56 0.0005
535 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
536 KIDNEY INFECTION 9 0.0005
537 WOUND INFECTION 5 0.0005
538 HYPERKALAEMIA 16 0.0005
539 GROIN PAIN 4 0.0005
540 INJECTION SITE NODULE 5 0.0005
541 LUNG INFILTRATION 4 0.0005
542 APPETITE DISORDER 3 0.0005
543 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
544 LIP SWELLING 15 0.0004
545 CARDIAC FAILURE ACUTE 3 0.0004
546 OXYGEN SATURATION DECREASED 25 0.0004
547 BLOOD BILIRUBIN INCREASED 12 0.0004
548 TASTE DISORDER 9 0.0004
549 EXTRAPYRAMIDAL DISORDER 11 0.0004
550 BONE MARROW FAILURE 9 0.0004
551 FLUSHING 45 0.0004
552 FLATULENCE 25 0.0004
553 ABDOMINAL DISTENSION 46 0.0004
554 CONFUSIONAL STATE 71 0.0004
555 SEPTIC SHOCK 19 0.0004
556 LYMPHOEDEMA 3 0.0004
557 ENCEPHALITIS 3 0.0004
558 UROSEPSIS 4 0.0004
559 PULMONARY HYPERTENSION 9 0.0004
560 VOMITING 203 0.0004
561 BLOOD GLUCOSE INCREASED 81 0.0004
562 DISORIENTATION 17 0.0004
563 SKIN EXFOLIATION 36 0.0004
564 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
565 OEDEMA 23 0.0004
566 SEASONAL ALLERGY 6 0.0004
567 COLITIS MICROSCOPIC 2 0.0004
568 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
569 CHOLECYSTITIS 5 0.0004
570 ENDOMETRIOSIS 2 0.0004
571 DYSKINESIA 17 0.0004
572 HYPERTHYROIDISM 6 0.0004
573 INFLUENZA LIKE ILLNESS 34 0.0004
574 INFLUENZA 46 0.0004
575 PHARYNGEAL SWELLING 4 0.0004
576 THROMBOCYTOPENIA 45 0.0004
577 PNEUMONIA 130 0.0004
578 HYDRONEPHROSIS 3 0.0004
579 ERYSIPELAS 2 0.0004
580 TOXIC SKIN ERUPTION 4 0.0004
581 SYSTEMIC LUPUS ERYTHEMATOSUS 14 0.0004
582 AMMONIA INCREASED 2 0.0004
583 BOWEL MOVEMENT IRREGULARITY 3 0.0004
584 HELICOBACTER INFECTION 4 0.0004
585 SYNOVITIS 7 0.0004
586 INSOMNIA 103 0.0004
587 BASAL CELL CARCINOMA 6 0.0004
588 PLASMA CELL MYELOMA 15 0.0004
589 RESPIRATORY FAILURE 28 0.0004
590 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
591 BLOOD LACTIC ACID INCREASED 2 0.0004
592 DYSPHAGIA 36 0.0004
593 ILL-DEFINED DISORDER 23 0.0004
594 DRUG INTERACTION 60 0.0004
595 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
596 DYSMENORRHOEA 5 0.0004
597 ABDOMINAL DISCOMFORT 63 0.0004
598 DIARRHOEA 242 0.0004
599 HYPOTENSION 75 0.0004
600 MIOSIS 3 0.0004
601 BREAST CANCER METASTATIC 4 0.0004
602 STENT PLACEMENT 3 0.0004
603 MALAISE 163 0.0004
604 PAIN OF SKIN 10 0.0004
605 MENTAL IMPAIRMENT 9 0.0004
606 FALL 123 0.0004
607 UVEITIS 5 0.0004
608 PNEUMONITIS 10 0.0004
609 HEPATIC ENZYME INCREASED 25 0.0004
610 ENCEPHALOPATHY 9 0.0004
611 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66 0.0004
612 OESOPHAGITIS 4 0.0004
613 CHOLESTASIS 7 0.0004
614 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
615 AUTISM SPECTRUM DISORDER 2 0.0004
616 DEAFNESS UNILATERAL 2 0.0004
617 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
618 RESPIRATORY DISTRESS 10 0.0004
619 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
620 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
621 STEVENS-JOHNSON SYNDROME 8 0.0004
622 ACUTE KIDNEY INJURY 55 0.0004
623 ORAL HERPES 7 0.0004
624 CONDITION AGGRAVATED 109 0.0004
625 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
626 DRUG USE DISORDER 3 0.0004
627 ACUTE PULMONARY OEDEMA 2 0.0004
628 FISTULA 4 0.0004
629 FACE OEDEMA 6 0.0004
630 LIMB DISCOMFORT 11 0.0004
631 OSTEOARTHRITIS 15 0.0004
632 MYOCARDIAL ISCHAEMIA 4 0.0004
633 NAUSEA 278 0.0004
634 BRONCHOSPASM 5 0.0004
635 PSEUDOMONAS INFECTION 3 0.0003
636 RED BLOOD CELL COUNT DECREASED 10 0.0003
637 SUBDURAL HAEMATOMA 5 0.0003
638 SOMNOLENCE 70 0.0003
639 ENTEROCOLITIS 2 0.0003
640 BLOOD URIC ACID INCREASED 2 0.0003
641 HEADACHE 217 0.0003
642 HAEMATOCHEZIA 19 0.0003
643 SPINAL PAIN 4 0.0003
644 DECREASED APPETITE 79 0.0003
645 BLOOD IRON DECREASED 4 0.0003
646 HAEMOLYTIC ANAEMIA 3 0.0003
647 RESPIRATORY DISORDER 10 0.0003
648 DYSPNOEA 189 0.0003
649 HEAVY MENSTRUAL BLEEDING 3 0.0003
650 BLOOD POTASSIUM DECREASED 10 0.0003
651 MALIGNANT NEOPLASM PROGRESSION 34 0.0003
652 HOT FLUSH 25 0.0003
653 FEBRILE NEUTROPENIA 22 0.0003
654 TOOTHACHE 6 0.0003
655 MUSCULOSKELETAL STIFFNESS 29 0.0003
656 ERYTHEMA 68 0.0003
657 CEREBROVASCULAR ACCIDENT 56 0.0003
658 MOOD ALTERED 9 0.0003
659 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
660 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
661 INJECTION SITE EXTRAVASATION 4 0.0003
662 RENAL DISORDER 15 0.0003
663 WEIGHT INCREASED 72 0.0003
664 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
665 BACK PAIN 74 0.0003
666 BLOOD SODIUM DECREASED 6 0.0003
667 DERMATITIS ALLERGIC 4 0.0003
668 CYANOSIS 5 0.0003
669 BLEPHAROSPASM 2 0.0003
670 DELIRIUM 11 0.0003
671 SPUTUM DISCOLOURED 3 0.0003
672 DISTURBANCE IN ATTENTION 17 0.0003
673 PAIN 193 0.0003
674 SCIATICA 5 0.0003
675 ENTERITIS 2 0.0003
676 INFECTION 45 0.0003
677 SINUS BRADYCARDIA 3 0.0003
678 CARDIAC FLUTTER 2 0.0003
679 EAR PAIN 6 0.0003
680 ANGINA UNSTABLE 2 0.0003
681 CONSTIPATION 67 0.0003
682 RESPIRATORY TRACT INFECTION 8 0.0003
683 PSORIASIS 40 0.0003
684 MEDICATION ERROR 17 0.0003
685 SHOCK 7 0.0003
686 ORAL CANDIDIASIS 4 0.0003
687 OEDEMA PERIPHERAL 37 0.0003
688 ANKYLOSING SPONDYLITIS 4 0.0003
689 PHOTOSENSITIVITY REACTION 5 0.0003
690 CHRONIC KIDNEY DISEASE 23 0.0003
691 DRUG LEVEL INCREASED 5 0.0003
692 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
693 UNDERDOSE 22 0.0003
694 CONTUSION 29 0.0003
695 CYTOMEGALOVIRUS INFECTION 5 0.0003
696 ARTHRALGIA 125 0.0003
697 BURNING SENSATION 21 0.0003
698 CARDIAC FAILURE 24 0.0003
699 EYE PRURITUS 10 0.0003
700 PLEURAL EFFUSION 18 0.0003
701 DRUG LEVEL DECREASED 3 0.0003
702 PERIPHERAL SWELLING 45 0.0003
703 FATIGUE 227 0.0003
704 NASAL CONGESTION 17 0.0003
705 MULTI-ORGAN FAILURE 5 0.0003
706 FEELING ABNORMAL 69 0.0003
707 ORAL DISCOMFORT 4 0.0003
708 NEUTROPENIA 39 0.0003
709 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
710 EXTRASYSTOLES 2 0.0003
711 DERMATITIS 6 0.0003
712 DEHYDRATION 38 0.0003
713 MOUTH ULCERATION 6 0.0003
714 SKIN REACTION 4 0.0003
715 INCONTINENCE 3 0.0003
716 SUDDEN DEATH 3 0.0003
717 DRY MOUTH 23 0.0003
718 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
719 IMPAIRED WORK ABILITY 6 0.0003
720 BREAST CANCER 26 0.0003
721 POOR QUALITY SLEEP 6 0.0003
722 CELLULITIS 14 0.0003
723 HYPERGLYCAEMIA 10 0.0003
724 ASTHMA 31 0.0003
725 INJECTION SITE SWELLING 21 0.0003
726 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
727 ANAPHYLACTIC SHOCK 7 0.0003
728 CEREBRAL DISORDER 2 0.0003
729 RASH MACULO-PAPULAR 6 0.0003
730 THROAT IRRITATION 12 0.0003
731 INTESTINAL PERFORATION 3 0.0003
732 ANXIETY 76 0.0003
733 EYE INFECTION 3 0.0003
734 STATUS EPILEPTICUS 3 0.0003
735 LUNG DISORDER 13 0.0003
736 CHOLECYSTECTOMY 3 0.0003
737 FEELING JITTERY 5 0.0003
738 EPILEPSY 8 0.0003
739 ACUTE RESPIRATORY FAILURE 5 0.0003
740 RENAL FAILURE ACUTE 11 0.0003
741 LYMPHOMA 4 0.0003
742 APHTHOUS ULCER 2 0.0003
743 APNOEA 2 0.0003
744 SWELLING 24 0.0003
745 DISABILITY 5 0.0003
746 HEAD INJURY 8 0.0003
747 BACTERAEMIA 3 0.0003
748 ATAXIA 3 0.0003
749 PRESCRIBED UNDERDOSE 5 0.0003
750 NECK PAIN 14 0.0003
751 RENAL IMPAIRMENT 21 0.0002
752 DIABETIC KETOACIDOSIS 6 0.0002
753 SENSORY DISTURBANCE 4 0.0002
754 OFF LABEL USE 216 0.0002
755 PSORIATIC ARTHROPATHY 10 0.0002
756 CARDIAC DISORDER 23 0.0002
757 SWELLING FACE 16 0.0002
758 DECUBITUS ULCER 2 0.0002
759 ASPHYXIA 2 0.0002
760 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
761 ACUTE CORONARY SYNDROME 2 0.0002
762 EOSINOPHIL COUNT INCREASED 2 0.0002
763 RHABDOMYOLYSIS 10 0.0002
764 ALOPECIA 47 0.0002
765 POISONING 3 0.0002
766 WHEEZING 14 0.0002
767 HEPATITIS 6 0.0002
768 MUSCLE SPASMS 43 0.0002
769 INJECTION SITE ERYTHEMA 29 0.0002
770 COVID-19 41 0.0002
771 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
772 IRRITABILITY 14 0.0002
773 INFUSION SITE PAIN 3 0.0002
774 CARDIAC MURMUR 2 0.0002
775 AMNESIA 15 0.0002
776 MIGRAINE 22 0.0002
777 PLATELET COUNT INCREASED 3 0.0002
778 DEAFNESS 6 0.0002
779 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
780 INTENTIONAL PRODUCT MISUSE 20 0.0002
781 NEUROTOXICITY 4 0.0002
782 LIVER DISORDER 10 0.0002
783 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
784 GALLBLADDER DISORDER 4 0.0002
785 DYSPEPSIA 22 0.0002
786 JAUNDICE 6 0.0002
787 PRODUCT USE IN UNAPPROVED INDICATION 55 0.0002
788 GAIT DISTURBANCE 42 0.0002
789 OSTEOPOROSIS 9 0.0002
790 RESTLESSNESS 8 0.0002
791 DEPRESSION 49 0.0002
792 HAEMOPTYSIS 6 0.0002
793 ERYTHEMA MULTIFORME 2 0.0002
794 CARPAL TUNNEL SYNDROME 3 0.0002
795 DYSPNOEA EXERTIONAL 8 0.0002
796 LYMPHOPENIA 3 0.0002
797 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
798 OCULAR HYPERAEMIA 10 0.0002
799 BLOOD URINE PRESENT 4 0.0002
800 PAIN IN EXTREMITY 62 0.0002
801 PROTEINURIA 4 0.0002
802 VISUAL IMPAIRMENT 26 0.0002
803 URINARY RETENTION 7 0.0002
804 DRY SKIN 28 0.0002
805 SLEEP APNOEA SYNDROME 4 0.0002
806 IMPAIRED QUALITY OF LIFE 3 0.0002
807 DIZZINESS 104 0.0002
808 PRODUCT USE ISSUE 39 0.0002
809 MYELODYSPLASTIC SYNDROME 3 0.0002
810 HYPOKINESIA 3 0.0002
811 DYSTONIA 4 0.0002
812 NEURALGIA 5 0.0002
813 AUTOIMMUNE DISORDER 2 0.0002
814 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
815 HAEMATOCRIT DECREASED 4 0.0002
816 HALLUCINATION 15 0.0002
817 HYPOAESTHESIA ORAL 3 0.0002
818 HYPOXIA 7 0.0002
819 EMPHYSEMA 2 0.0002
820 THERAPEUTIC RESPONSE DECREASED 12 0.0002
821 ARTHROPATHY 11 0.0002
822 LYMPHADENOPATHY 7 0.0002
823 VERTIGO 12 0.0002
824 BODY TEMPERATURE INCREASED 4 0.0002
825 INJECTION SITE WARMTH 4 0.0002
826 OROPHARYNGEAL PAIN 18 0.0002
827 TENDONITIS 3 0.0002
828 LUNG INFECTION 3 0.0002
829 SWOLLEN TONGUE 6 0.0002
830 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
831 MUCOSAL INFLAMMATION 5 0.0002
832 DISEASE RECURRENCE 9 0.0002
833 HYPOTHYROIDISM 6 0.0002
834 BONE PAIN 11 0.0002
835 JOINT INJURY 4 0.0002
836 TREMOR 31 0.0002
837 RASH 81 0.0002
838 ATRIAL FIBRILLATION 18 0.0002
839 COLITIS 7 0.0002
840 SLEEP DISORDER 13 0.0002
841 ASPIRATION 2 0.0002
842 STAPHYLOCOCCAL INFECTION 6 0.0002
843 URINARY TRACT INFECTION 31 0.0002
844 VIRAL INFECTION 6 0.0002
845 COAGULOPATHY 3 0.0002
846 MENTAL STATUS CHANGES 5 0.0002
847 GLOSSODYNIA 4 0.0002
848 PANCREATITIS ACUTE 4 0.0002
849 CANDIDA INFECTION 3 0.0002
850 ANGER 6 0.0002
851 CIRCULATORY COLLAPSE 3 0.0002
852 DERMATITIS CONTACT 2 0.0002
853 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
854 BALANCE DISORDER 15 0.0002
855 ECZEMA 9 0.0002
856 LOSS OF CONSCIOUSNESS 22 0.0002
857 RASH MACULAR 6 0.0002
858 PANCREATITIS 9 0.0002
859 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
860 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
861 VISION BLURRED 23 0.0002
862 ROAD TRAFFIC ACCIDENT 7 0.0002
863 GASTROENTERITIS VIRAL 3 0.0002
864 HEPATIC FAILURE 5 0.0002
865 CRYING 6 0.0002
866 RESTLESS LEGS SYNDROME 3 0.0002
867 SUICIDE ATTEMPT 10 0.0002
868 CEREBRAL INFARCTION 4 0.0002
869 FEELING HOT 10 0.0002
870 INJECTION SITE BRUISING 13 0.0002
871 BRONCHITIS 12 0.0002
872 AGRANULOCYTOSIS 3 0.0002
873 CYST 2 0.0002
874 MENTAL DISORDER 7 0.0002
875 MEMORY IMPAIRMENT 22 0.0002
876 PNEUMONIA ASPIRATION 4 0.0002
877 DIABETES MELLITUS 12 0.0002
878 EYE IRRITATION 9 0.0002
879 PRODUCT SUBSTITUTION ISSUE 9 0.0002
880 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
881 HERNIA 3 0.0002
882 HAEMATOMA 4 0.0002
883 HYPOAESTHESIA 23 0.0002
884 DEPRESSED MOOD 8 0.0002
885 HYPERSENSITIVITY 28 0.0002
886 SPINAL FRACTURE 3 0.0001
887 LIMB INJURY 4 0.0001
888 RENAL FAILURE 19 0.0001
889 INJURY 10 0.0001
890 HALLUCINATION, VISUAL 3 0.0001
891 DRY EYE 7 0.0001
892 AGGRESSION 7 0.0001
893 PARAESTHESIA 22 0.0001
894 CARDIOGENIC SHOCK 2 0.0001
895 HYPOACUSIS 6 0.0001
896 SKIN CANCER 3 0.0001
897 MYOCARDIAL INFARCTION 24 0.0001
898 LIVER FUNCTION TEST ABNORMAL 4 0.0001
899 PSYCHOTIC DISORDER 4 0.0001
900 ORAL PAIN 3 0.0001
901 SPEECH DISORDER 7 0.0001
902 CHROMATURIA 3 0.0001
903 STOMATITIS 8 0.0001
904 ACNE 10 0.0001
905 DRUG DISPENSING ERROR 2 0.0001
906 TOXICITY TO VARIOUS AGENTS 22 0.0001
907 DEVICE RELATED INFECTION 2 0.0001
908 BONE DENSITY DECREASED 4 0.0001
909 PULMONARY EMBOLISM 12 0.0001
910 RASH ERYTHEMATOUS 6 0.0001
911 BLISTER 7 0.0001
912 LACTIC ACIDOSIS 4 0.0001
913 BLOOD POTASSIUM INCREASED 2 0.0001
914 IMPAIRED HEALING 4 0.0001
915 OSTEONECROSIS OF JAW 3 0.0001
916 EPISTAXIS 9 0.0001
917 FUNGAL INFECTION 4 0.0001
918 POLLAKIURIA 5 0.0001
919 NEOPLASM MALIGNANT 8 0.0001
920 INJECTION SITE PRURITUS 8 0.0001
921 ADVERSE EVENT 11 0.0001
922 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
923 HYPOPHAGIA 3 0.0001
924 RECTAL HAEMORRHAGE 5 0.0001
925 UNRESPONSIVE TO STIMULI 3 0.0001
926 NEOPLASM PROGRESSION 4 0.0001
927 EOSINOPHILIA 2 0.0001
928 INJECTION SITE PAIN 35 0.0001
929 DRUG INEFFECTIVE 150 0.0001
930 EAR INFECTION 3 0.0001
931 THROMBOSIS 9 0.0001
932 SKIN BURNING SENSATION 8 0.0001
933 ADVERSE DRUG REACTION 10 0.0001
934 SKIN DISCOLOURATION 5 0.0001
935 DYSURIA 4 0.0001
936 COMPLETED SUICIDE 9 0.0001
937 URTICARIA 18 0.0001
938 PANCYTOPENIA 6 0.0001
939 DEMENTIA 3 0.0001
940 OVERDOSE 23 0.0001
941 INTENTIONAL DOSE OMISSION 3 0.0001
942 CONVULSION 6 0.0001
943 HERPES ZOSTER 6 0.0001
944 DYSPHONIA 6 0.0001
945 URINARY INCONTINENCE 3 0.0001
946 OESOPHAGEAL CARCINOMA 3 0.0001
947 EMOTIONAL DISORDER 3 0.0001
948 INTENTIONAL OVERDOSE 6 0.0001
949 ANAPHYLACTIC REACTION 5 0.0001
950 VISUAL ACUITY REDUCED 3 0.0001
951 SKIN DISORDER 3 0.0001
952 COLITIS ULCERATIVE 4 0.0001
953 PANIC ATTACK 3 0.0001
954 DISCOMFORT 5 0.0001
955 EXPOSURE DURING PREGNANCY 5 0.0001
956 DEEP VEIN THROMBOSIS 5 0.0001
957 ANHEDONIA 2 0.0001
958 ABNORMAL DREAMS 2 0.0001
959 FEELING COLD 2 0.0001
960 ILLNESS 7 0.0001
961 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
962 THERAPY NON-RESPONDER 3 0.0001
963 SUICIDAL IDEATION 6 0.0001
964 HOSPITALISATION 10 0.0001
965 INJECTION SITE HAEMORRHAGE 5 0.0001
966 PRODUCT DOSE OMISSION 4 0.0001
967 EYE DISORDER 2 0.0001
968 CARDIAC ARREST 5 0.0001
969 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
970 DRUG EFFECT DECREASED 3 0.0001
971 MOBILITY DECREASED 4 0.0001
972 EYE SWELLING 2 0.0001
973 INCORRECT DOSE ADMINISTERED 12 0.0001
974 SEIZURE 6 0.0001
975 EMOTIONAL DISTRESS 6 0.0000
976 PRODUCT STORAGE ERROR 4 0.0000
977 PRODUCT DOSE OMISSION ISSUE 13 0.0000
978 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
979 DEVICE MALFUNCTION 3 0.0000
980 DISEASE PROGRESSION 5 0.0000
981 BLOOD GLUCOSE DECREASED 2 0.0000
982 DYSGEUSIA 3 0.0000
983 UNEVALUABLE EVENT 3 0.0000
984 HAEMORRHAGE 4 0.0000
985 DERMATITIS ATOPIC 2 0.0000
986 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
987 DEATH 28 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
989 DRUG WITHDRAWAL SYNDROME 2 0.0000
990 DRUG DEPENDENCE 3 0.0000
991 NO ADVERSE EVENT 3 0.0000
992 DRUG DOSE OMISSION 2 0.0000